Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.06 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |